3D 세포배양 시장 보고서 : 제품별, 용도별, 최종 사용자별, 지역별(2024-2032년)

The global 3D cell culture market size reached US$ 2,323.2 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 7,418.7 Million by 2032, exhibiting a growth rate (CAGR) of 13.4% during 2024-2032. The growing demand for 3D tissue-engineered models to diagnose cancer, rising need for airway and air-liquid interface organoids, and increasing utilization in studies that require in vivo model systems represent some of the key factors driving the market.

3D cell culture is a culture environment that enables cells to grow and interact with surrounding extracellular frameworks in three dimensions. It is a contrast to traditional 2D cell cultures wherein cells are grown in a flat monolayer on a plate. It can be cultured within supporting scaffolds, such as hydrogels and inert matrices, to allow growth in all directions. It relies on scaffold-free methods, such as low-adhesion plates, micropatterned surfaces, and hanging drops, for allowing cells to self-assemble into clusters or spheroids. It is performed within the chambers of a microchip that allows the flow of liquid to transport and distribute nutrients or other chemicals throughout the cells. It represents more accurately the actual microenvironment wherein cells reside in tissues compared to 2D cell culture. As it is more reflective of in vivo cellular responses due to the additional dimensionality of 3D cultures, the demand for 3D cell culture is rising across the globe.

3D Cell Culture Market Trends:

At present, the increasing utilization of 3D cell culture in studies that require in vivo model systems, as 3D cultures can closely mimic a typical morphology and microarchitecture of organs, represents one of the key factors supporting the growth of the market. Besides this, there is a rise in the employment of 3D tissue-engineered models to diagnose cancer and other clinical disorders among the masses around the world. This, along with the growing demand for 3D cell culture to analyze the effects of a foreign drug over body tissues and organs, is offering a favorable market outlook. In addition, the rising demand for 3D cell culture, as it is a simple and inexpensive in vitro tumor-host environment compared to 2D techniques, is propelling the growth of the market. Moreover, the increasing usage of 3D models for performing research about respiratory diseases is offering lucrative growth opportunities to industry investors. Apart from this, there is an increase in the demand for airway and air-liquid interface organoids to develop and discover antiviral drugs and as experimental virology platforms and study the immune responses. This, coupled with the launch of new products and wide applications of 3D protocols in biological research, is strengthening the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global 3D cell culture market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, application and end user.

Product Insights:

• Scaffold-Based Platforms
• Scaffold-Free Platforms
• Microchips
• Bioreactors
• Others

The report has provided a detailed breakup and analysis of the 3D cell culture market based on the product. This includes scaffold-based platforms, scaffold-free platforms, microchips, bioreactors, and others. According to the report, scaffold-based platforms represented the largest segment.

Application Insights:

• Cancer Research
• Stem Cell Research
• Drug Discovery
• Regenerative Medicine
• Others

A detailed breakup and analysis of the 3D cell culture market based on the application has also been provided in the report. This includes cancer research, stem cell research, drug discovery, regenerative medicine, and others. According to the report, cancer research accounted for the largest market share.

End User Insights:

• Biotechnology and Pharmaceutical Companies
• Contract Research Laboratories
• Academic Institutes
• Others

A detailed breakup and analysis of the 3D cell culture market based on the end user has also been provided in the report. This includes biotechnology and pharmaceutical companies, contract research laboratories, academic institutes, and others. According to the report, biotechnology and pharmaceutical companies accounted for the largest market share.

Regional Insights:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America (the United States and Canada) was the largest market for 3D cell culture. Some of the factors driving the North America 3D cell culture market included the government funding for the development of advanced 3D cell culture models, high healthcare spending, the presence of a large number of universities and research organizations, etc.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global 3D cell culture market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include 3D Biotek LLC, Advanced Biomatrix Inc., Avantor Inc., CN Bio Innovations Limited, Corning Incorporated, Emulate Inc., InSphero AG, Lonza Group AG, Merck KGaA, Promocell GmbH, Synthecon Inc, Thermo Fisher Scientific Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

• 1. How big is the 3D cell culture market?
• 2. What is the expected growth rate of the global 3D cell culture market during 2024-2032?
• 3. What are the key factors driving the global 3D cell culture market?
• 4. What has been the impact of COVID-19 on the global 3D cell culture market?
• 5. What is the breakup of the global 3D cell culture market based on the product?
• 6. What is the breakup of the global 3D cell culture market based on the application?
• 7. What is the breakup of the global 3D cell culture market based on the end user?
• 8. What are the key regions in the global 3D cell culture market?
• 9. Who are the key players/companies in the global 3D cell culture market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global 3D Cell Culture Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Scaffold-Based Platforms
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Scaffold-Free Platforms
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Microchips
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Bioreactors
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast
• 6.5 Others
  • 6.5.1 Market Trends
  • 6.5.2 Market Forecast

7 Market Breakup by Application

• 7.1 Cancer Research
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Stem Cell Research
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Drug Discovery
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Regenerative Medicine
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast
• 7.5 Others
  • 7.5.1 Market Trends
  • 7.5.2 Market Forecast

8 Market Breakup by End User

• 8.1 Biotechnology and Pharmaceutical Companies
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Contract Research Laboratories
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Academic Institutes
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Others
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 3D Biotek LLC
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
  • 14.3.2 Advanced Biomatrix Inc.
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
  • 14.3.3 Avantor Inc.
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
    • 14.3.3.3 Financials
  • 14.3.4 CN Bio Innovations Limited
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
  • 14.3.5 Corning Incorporated
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
    • 14.3.5.3 Financials
    • 14.3.5.4 SWOT Analysis
  • 14.3.6 Emulate Inc.
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
  • 14.3.7 InSphero AG
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
  • 14.3.8 Lonza Group AG
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
    • 14.3.8.3 Financials
    • 14.3.8.4 SWOT Analysis
  • 14.3.9 Merck KGaA
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
    • 14.3.9.3 Financials
    • 14.3.9.4 SWOT Analysis
  • 14.3.10 Promocell GmbH
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
  • 14.3.11 Synthecon Inc
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio
  • 14.3.12 Thermo Fisher Scientific Inc.
    • 14.3.12.1 Company Overview
    • 14.3.12.2 Product Portfolio
    • 14.3.12.3 Financials
    • 14.3.12.4 SWOT Analysis